ASHLEIGH LUSSENDEN advises life sciences companies across the full range of transactional matters, including strategic collaborations, licensing, acquisitions and divestitures, and a variety of commercial and clinical agreements.
Ashleigh utilizes her scientific training gained pursuing her Ph.D. in neuroscience to bring a deep understanding of science to intellectual property-focused strategic transactions. Ashleigh’s Ph.D. thesis focused on the role of schizophrenia susceptibility genes in early embryonic neuronal development. During her graduate education, she utilized in vitro, ex vivo, and in vivo cell and animal models to measure and track neuronal development. Employing cell culture, live-cell imaging, immunofluorescence, and tissue sectioning to examine development, Ashleigh became familiar with a breadth of modalities and protocols. In addition to the research Ashleigh performed during graduate school, she also participated in science policy advocacy and scientific literacy programming for local schools and the New York Academy of Sciences.
Ashleigh received a Graduate Student Research Fellowship from the National Science Foundation as a graduate student, and subsequently assisted several other students in her department write successful NSF grant proposals. She was awarded a Turner Fellowship at Stony Brook University and a Dean’s Fellowship, Philip Frickey Fellowship, and Marcus Fellowship at Berkeley Law. During law school, she was a Miller Fellow at the Miller Center for The Miller Institute for Global Challenges and the Law, earned an International Law Certificate, a Public Interest & Social Justice Certificate, Jurisprudence Awards in Federal Indian Law and International Human Rights, and the Francine Marie Diaz Memorial Award.